2021 ASH Annual Meeting: Plenary Abstract on ATLAS-INH in Patients With Hemophilia A or B With Inhibitors, Drs. Guy Young & Laura Michaelis

Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Guy Young about his work on the ATLAS-INH study in patients with hemophilia A or B with inhibitors, a plenary abstract that will be presented at the 2021 ASH Annual Meeting's Plenary Scientific session on Sunday, December 12.

Show Notes

In this installment of our 2021 ASH Annual Meeting Podcast series, Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Guy Young about his work on one of the plenary abstracts that will be presented at the 2021 ASH Annual Meeting. The abstract evaluates the efficacy and safety of fitusiran prophylaxis in a multicenter phase 3 study (ATLAS-INH) in patients with hemophilia A or B with inhibitors.
For coverage of the plenary scientific session, including this abstract and many other sessions, check www.ashpublications.org/ashnewsdaily throughout the meeting.       
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

What is The Hematologist?

The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.